TRIM44 and Miyoshi myopathy: Moreover, a novel MM prognostic marker, a tripartite motif family member (TRIM44), has been proposed as a potential biomarker for MM, since it has been found to be overexpressed in 858 patients with poor prognosis and resistance to BTZ.